BETHANY CAHILL: Open Payments
NPI 1548894165 · NORFOLK, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$589 in 18 payments from 11 companies in 2025. Trend: 2023 $858 · 2024 $188 · 2025 $589
Food & beverage: $589
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 2 | $132 |
| Xeris Pharmaceuticals, Inc. | 1 | $122 |
| PFIZER INC. | 3 | $74 |
| Dexcom, Inc. | 3 | $54 |
| KYOWA KIRIN, INC. | 2 | $51 |
| Exact Sciences Corporation | 2 | $42 |
| Axsome Therapeutics, Inc. | 1 | $37 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $21 |
| GlaxoSmithKline, LLC. | 1 | $21 |
| Astellas Pharma US Inc | 1 | $18 |
Products named: RECORLEV, ZAVZPRET, Dexcom G6 Transmitter, CRYSVITA, Cologuard Collection Kit, Auvelity, Ozempic, CAPLYTA.
Industry payments across VA — which companies pay providers there.
